Skip to main content

Table 2 Effect of chronic A. marmelos extract treatment on lipid profiles in diabetic rats

From: Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos

Groups

Total cholesterol (mg/dL)

Triglycerides (mg/dL)

HDL-cholesterol (mg/dL)

LDL-cholesterol (mg/dL)

 

Day 1

Day 43

Day 1

Day 43

Day 1

Day 43

Day 1

Day 43

Control (n = 11)

47.3 ± 2.4

49.9 ± 2.4

33.8 ± 2.5

35.4 ± 2.4

26.8 ± 1.4

25.7 ± 1.3

18.2 ± 3.3

19.2 ± 2.86

Db (n = 8)

45.3 ± 2.4

40.1 ± 1.7

49.9 ± 3.5

54.2 ± 3.1

12.0 ± 1.0

10.3 ± 1.2

23.1 ± 2.6

26.9 ± 1.92

AM (n = 6)

44.6 ± 1.2

43.0 ± 3.0

50.6 ± 3.1

36.1 ± 3.5***

13.3 ± 1.0

20.1 ± 1.3***

21.7 ± 1.8

15.6 ± 2.20*

Gb (n = 6)

42.8 ± 2.8

46.0 ± 3.2

50.5 ± 2.8

39.0 ± 1.1**

14.1 ± 1.7

18.0 ± 1.1**

22.7 ± 1.6

20.1 ± 3.11

  1. All values were expressed as mean ± SEM. Control, non-diabetic control rats; Db, untreated diabetic rats; AM, A. marmelos-treated rats; Gb, glibenclamide-treated rats. n = number of rats in each group. *p < 0.05, **p < 0.01, ***p < 0.001, compared with Db values (one-way ANOVA with Dunnett’s multicomparison test)